BioCryst Pharmaceuticals
BCRX
#5073
Rank
S$2.07 B
Marketcap
S$9.84
Share price
-3.07%
Change (1 day)
-3.63%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.57 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are S$0.57 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$0.66 B-2.36%
2023-12-31S$0.68 B-7.4%
2022-12-31S$0.73 B-7.27%
2021-12-31S$0.79 B79.56%
2020-12-31S$0.44 B87.38%
2019-12-31S$0.23 B17.8%
2018-12-31S$0.20 B-15.86%
2017-12-31S$0.23 B83.35%
2016-12-31S$0.13 B-24.87%
2015-12-31S$0.17 B-4.3%
2014-12-31S$0.18 B192.12%
2013-12-31S$61.91 M-11.86%
2012-12-31S$70.24 M-34.02%
2011-12-31S$0.10 B-24.48%
2010-12-31S$0.14 B-29.38%
2009-12-31S$0.19 B64.82%
2008-12-31S$0.12 B-41.02%
2007-12-31S$0.20 B95.56%
2006-12-31S$0.10 B-36.45%
2005-12-31S$0.16 B211.97%
2004-12-31S$52.96 M3.59%
2003-12-31S$51.13 M-28.65%
2002-12-31S$71.66 M-34.5%
2001-12-31S$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
S$3.78 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$4.52 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$11.43 M-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.52 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$75.85 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.84 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.86 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
S$1.89 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$26.35 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA